И А Смирнова
Ministry of Health of the Russian Federation · 29 works · 1,129 citations · h-index 8
Top works
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
- S4-8: First results of AVEREL, a randomized phase III trial to evaluate bevacizumab (BEV) in combination with trastuzumab (H) + docetaxel (DOC) as first-line therapy for HER2−positive locally recurrent/metastatic breast cancer (LR/mBC)
- Abstract S1-4: Final analysis of overall survival for the Phase III CONFIRM trial: fulvestrant 500 mg versus 250 mg
- Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers
- A randomized, double-blind phase II trial of exemestane plus MM-121 (a monoclonal antibody targeting ErbB3) or placebo in postmenopausal women with locally advanced or metastatic ER+/PR+, HER2-negative breast cancer.
- Phase II trial of C1311, a novel inhibitor of topoisomerase II in advanced breast cancer
- Cationic control of gene transcription in tumour cells.
- The overview of modern approaches in treatment of triple negative breast cancer
- Polymorphism of genes for catechol-O-methyltransferase (COMT) and hemochromatosis (HFE) in residents of radiocontaminated regions varying in chromosome aberration frequency
- Differential expression of cellular genes in Rauscher leukaemia.
- Target therapy in treatment of HER2-positive breast cancer
- [Polyadenylated RNA and poly-A segments in the splenic cells of mice with virus-induced Rauscher leukemia].
- EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
- Интраоперационная лучевая терапия в комбинированном лечении рака молочной железы
- Application of new methodology to allow comparison of duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial
- Definition of leukemia associated genome reorganizations and ultra structural changes in leukocytes of blood of the liquidators in the remote terms after irradiation
- In vivo и in vitro индуцируемые эффекты Галавита на хемилюминесцентную активность мононуклеаров крови онкологических и неонкологических больных
- Polynucleotide sequences in the DNA of leukemia cells that form RNAase-resistant complexes with polyuridylic acid
- Сочетанная фотонно-нейтронная терапия в комплексном лечении больных раком молочной железы iiMv стадии